Onconova Therapeutics Inc (ONTX) 4.69 $ONTX
5 Stocks Under $10 Setting Up to Soar
at The Street - Thu Jun 26, 12:56PM CDT
These under-$10 stocks look poised to break out and trade higher from current levels.
4 Biotech Stocks Under $10 to Watch for Breakout Trades
at The Street - Fri Jun 20, 7:27AM CDT
These biotech stocks trading for under $10 are starting to push higher into breakout territory.
Onconova Therapeutics (ONTX) in Focus: Stock Up 14.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 8:46AM CDT
Onconova Therapeutics (ONTX) was a big mover last session, with shares rising just over 14% on the day.
Nasdaq stocks posting largest percentage increases
AP - Thu Jun 12, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
3 Stocks Under $10 Moving Higher
at The Street - Wed May 28, 6:45AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Human papillomavirus (HPV) Associated Cancer Therapeutics Pipeline Review 2014
M2 - Wed May 28, 5:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jtm329/human) has announced the addition of the "Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Human papillomavirus (HPV) Associated Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human papillomavirus (HPV) Associated Cancer and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Merck & Co., Inc. - 3SBio Inc. - Transgene SA - Prima BioMed Ltd. - Antigen Express, Inc. - Bionor Pharma ASA - PDS Biotechnology Corporation - Onconova Therapeutics, Inc. - Genexine, Inc. - Etubics Corporation - iBio, Inc. - Sirnaomics, Inc. - Cancer Therapeutics CRC Pty Ltd - EyeGene, Inc. - Vaccibody AS - VLP Biotech, Inc. - Coridon Pty Ltd For more information visit http://www.researchandmarkets.com/research/jtm329/human
Endocyte (ECYT) Soars: Stock Adds 94.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 7:51AM CDT
Endocyte, Inc. was a big mover last session, as its shares rose over 94% on the day.
Why Onconova Therapeutics (ONTX) Could Be a Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:47AM CDT
Onconova Therapeutics looks well positioned for a solid gain, but has been overlooked by investors lately
Is A Short Squeeze Ahead for Onconova (ONTX)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:18AM CDT
Is A Short Squeeze Ahead for Onconova (ONTX)?
Onconova (ONTX) is now in Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 6:55AM CDT
Onconova (ONTX) is now in Oversold Territory
Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014
GlobeNewswire - Mon Mar 10, 3:01PM CDT
Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today provided a corporate update and reported financial results for its year ended December 31, 2013.
Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call
GlobeNewswire - Tue Mar 04, 4:45PM CST
Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that financial results for the Company's fourth quarter and year ended December 31, 2013 will be released on Monday, March 10, 2014. The Company will host a conference call and audio webcast at 4:30 PM ET on the same day.
The Zacks Analyst Blog Highlights:Isis Pharmaceuticals, Onconova Therapeutics, Vertex Pharma, Biogen and FTI Consulting
PR Newswire - Thu Feb 27, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Isis Pharmaceuticals (Nasdaq:ISIS-Free Report), Onconova Therapeutics (Nasdaq:ONTX-Free Report), Vertex Pharma (Nasdaq:VRTX-Free Report), Biogen (Nasdaq:BIIB-Free Report) and FTI Consulting, Inc. (NYSE:FCN-Free Report).
5 Stocks Insiders Love Right Now
at The Street - Wed Feb 26, 10:35AM CST
Insiders at these companies have been scooping up shares of their own stock lately.
Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference
GlobeNewswire - Wed Feb 26, 8:22AM CST
Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Ramesh Kumar, Ph.D., President and CEO, will present at the Cowen and Company 34 Annual Health Care Conference in Boston, MA. The presentation will take place on Wednesday, March 5 at 11:20 a.m. ET.
4 Biotech Stocks Under $10 Moving Higher
at The Street - Wed Feb 26, 5:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!
Sean Williams, The Motley Fool - Motley Fool - Sat Feb 22, 11:20AM CST
With the SPDR S&P Biotech Index up 75% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Feb 22, 7:38AM CST
It's always fun watching the best of the best compete in the Winter Olympic games. But, of course, not everyone can win. Plenty of athletes experience the proverbial agony of defeat. That's the case with investing, too. Not every stock can be a...
Onconova's Rigosertib Misses Primary Endpoint - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 5:40PM CST
Onconov's rigosertib failed to meet its primary endpoint of significant improvement in median overall survival in the ONTIME study
Why Onconova Therapeutics Inc. Shares Imploded
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 20, 12:02PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Onconova Therapeutics , a clinical-stage...
5 Stocks Under $10 Setting Up to Soar
at The Street - Thu Jun 26, 12:56PM CDT
These under-$10 stocks look poised to break out and trade higher from current levels.
4 Biotech Stocks Under $10 to Watch for Breakout Trades
at The Street - Fri Jun 20, 7:27AM CDT
These biotech stocks trading for under $10 are starting to push higher into breakout territory.
Onconova Therapeutics (ONTX) in Focus: Stock Up 14.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 8:46AM CDT
Onconova Therapeutics (ONTX) was a big mover last session, with shares rising just over 14% on the day.
Nasdaq stocks posting largest percentage increases
AP - Thu Jun 12, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
3 Stocks Under $10 Moving Higher
at The Street - Wed May 28, 6:45AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Human papillomavirus (HPV) Associated Cancer Therapeutics Pipeline Review 2014
M2 - Wed May 28, 5:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jtm329/human) has announced the addition of the "Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Human papillomavirus (HPV) Associated Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human papillomavirus (HPV) Associated Cancer and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Merck & Co., Inc. - 3SBio Inc. - Transgene SA - Prima BioMed Ltd. - Antigen Express, Inc. - Bionor Pharma ASA - PDS Biotechnology Corporation - Onconova Therapeutics, Inc. - Genexine, Inc. - Etubics Corporation - iBio, Inc. - Sirnaomics, Inc. - Cancer Therapeutics CRC Pty Ltd - EyeGene, Inc. - Vaccibody AS - VLP Biotech, Inc. - Coridon Pty Ltd For more information visit http://www.researchandmarkets.com/research/jtm329/human
Endocyte (ECYT) Soars: Stock Adds 94.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 7:51AM CDT
Endocyte, Inc. was a big mover last session, as its shares rose over 94% on the day.
Why Onconova Therapeutics (ONTX) Could Be a Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:47AM CDT
Onconova Therapeutics looks well positioned for a solid gain, but has been overlooked by investors lately
Is A Short Squeeze Ahead for Onconova (ONTX)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:18AM CDT
Is A Short Squeeze Ahead for Onconova (ONTX)?
Onconova (ONTX) is now in Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 6:55AM CDT
Onconova (ONTX) is now in Oversold Territory
Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014
GlobeNewswire - Mon Mar 10, 3:01PM CDT
Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today provided a corporate update and reported financial results for its year ended December 31, 2013.
Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call
GlobeNewswire - Tue Mar 04, 4:45PM CST
Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that financial results for the Company's fourth quarter and year ended December 31, 2013 will be released on Monday, March 10, 2014. The Company will host a conference call and audio webcast at 4:30 PM ET on the same day.
The Zacks Analyst Blog Highlights:Isis Pharmaceuticals, Onconova Therapeutics, Vertex Pharma, Biogen and FTI Consulting
PR Newswire - Thu Feb 27, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Isis Pharmaceuticals (Nasdaq:ISIS-Free Report), Onconova Therapeutics (Nasdaq:ONTX-Free Report), Vertex Pharma (Nasdaq:VRTX-Free Report), Biogen (Nasdaq:BIIB-Free Report) and FTI Consulting, Inc. (NYSE:FCN-Free Report).
5 Stocks Insiders Love Right Now
at The Street - Wed Feb 26, 10:35AM CST
Insiders at these companies have been scooping up shares of their own stock lately.
Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference
GlobeNewswire - Wed Feb 26, 8:22AM CST
Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Ramesh Kumar, Ph.D., President and CEO, will present at the Cowen and Company 34 Annual Health Care Conference in Boston, MA. The presentation will take place on Wednesday, March 5 at 11:20 a.m. ET.
4 Biotech Stocks Under $10 Moving Higher
at The Street - Wed Feb 26, 5:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!
Sean Williams, The Motley Fool - Motley Fool - Sat Feb 22, 11:20AM CST
With the SPDR S&P Biotech Index up 75% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Feb 22, 7:38AM CST
It's always fun watching the best of the best compete in the Winter Olympic games. But, of course, not everyone can win. Plenty of athletes experience the proverbial agony of defeat. That's the case with investing, too. Not every stock can be a...
Onconova's Rigosertib Misses Primary Endpoint - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 5:40PM CST
Onconov's rigosertib failed to meet its primary endpoint of significant improvement in median overall survival in the ONTIME study
Why Onconova Therapeutics Inc. Shares Imploded
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 20, 12:02PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Onconova Therapeutics , a clinical-stage...
